Search results for: 'Outsourcing of central materials and sterilization'
- Did you mean
- outsourcing of central materials ad sterilization
- Related search terms
- sterilization equipment and disinfection market
- Central European Wound Care and Wound Closure Market
- outsourcing services market colombia
- AND 6153=5227-- cSlQ
- sterilization equipment ad disinfection market
-
10 Jul 2025  |  Global  |  Technology Research
Technologies for Preventing Hospital-Acquired Infections—Innovations and Growth Opportunities
A comprehensive look at the role of AI, automation, and digital surveillance technologies, showcasing the innovations that drives towards real-time detection and prevention strategies of hospital-acquired infections
Hospital-acquired infections (HAI) occur 48 hours or more after hospital visit and were not present at the time of admission. Globally, around 136 million people are affected by HAIs every year. This increases the mortality rate and economic burden due to extended hospitalization and treatment. This report provides a comprehensive overview of vario...
$4,950.00
Special Price $4,455.00 save 10 %
-
25 Sep 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables
Advanced MedTech Technology Opportunity Engine
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based automated peritoneal dialysis, solid state ablation ...
$950.00 -
21 Mar 2025  |  Global  |  Market Research
Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030
The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model
As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...
$4,950.00
Special Price $4,455.00 save 10 %
-
31 May 2022  |  North America  |  Market Research
Global RNA Therapeutics Growth Opportunities
Future Growth Potential Driven by Co-Development Programs and Robust Clinical Trials for Diverse Disease Areas
Scientific advancements in nucleic acid-based therapies have significantly impacted the global biopharmaceutical industry. The ribonucleic acid (RNA) therapeutics market is expected to witness remarkable clinical progress as therapies target “undruggable” pathways. Technologically advanced platforms are integrated into RNA therapeutics bioprocessin...
$2,450.00
Special Price $1,837.50 save 25 %
-
19 Apr 2017  |  Asia Pacific  |  Market Research
Global CRO Market, Forecast to 2021
The Global CRO Market to Reach $64.58 Billion by 2021
The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...
$4,950.00
Special Price $3,712.50 save 25 %
-
04 Feb 2015  |  Global  |  Market Research
Global CRO Market
Transformation, Developments, Opportunities and Future of CRO Market
This research service presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type, and region. It addresses the major issues and challenges, unmet needs, and emerging trends in the market. Detailed information has been provided on s...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Aug 2020  |  Global  |  Market Research
Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024
Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities
In this research deliverable, Frost & Sullivan’s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new t...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Feb 2025  |  Global  |  Market Outlook
Top 6 Growth Opportunities in Pharma-Biotech, 2025
Unlocking Growth in Precision Therapeutics, Digital Innovation, Manufacturing, and Emerging Markets
The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...
$2,450.00
Special Price $2,205.00 save 10 %
-
23 Aug 2022  |  North America  |  Market Research
Global Bioanalytical Testing Services, 2021–2027
Acquisition of Disruptive Technologies will be the Key to Driving Growth
As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug dev...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Mar 2026  |  Global  |  Market Research
Growth Opportunities in Global Pharmaceutical Industry, 2026
Platforms, Policies, and Pathways: Convert Complexity into Growth
The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...
$4,950.00